Skip to Content

PLIVA 787 (Azithromycin monohydrate 250 mg)

Pill imprint PLIVA 787 has been identified as Azithromycin monohydrate 250 mg.

Azithromycin is used in the treatment of chlamydia infection; bacterial infection; upper respiratory tract infection; bronchitis; sinusitis (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Azithromycin 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Azithromycin monohydrate 250 mg PLIVA 787
Azithromycin monohydrate
250 mg
15.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Pliva Inc.
National Drug Code (NDC):
Inactive Ingredients:
corn starch
calcium phosphate dibasic anhydrous
croscarmellose sodium
hypromellose 2910 (15 mPa.s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 4000
trisodium citrate dihydrate
sodium lauryl sulfate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
58016-0086 Southwood Pharmaceuticals Inc (repackager)
16590-0362 Stat RX USA LLC (repackager)
55887-0785 Diversified Healthcare Services Inc (repackager)
18837-0338 Innoviant Pharmacy Inc (repackager)
43063-0090 PDRX Pharmaceuticals Inc (repackager)
53002-2224 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.